Arabic Arabic English English French French German German
dark

2seventy bio Shares Key Milestones and Business Updates for 2022

2seventy bio, Inc. (Nasdaq: TSVT), an emerging immuno-oncology cell therapy company, today provided an update on the company’s outlook for 2022. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Ketamine and psychological therapy helped severe alcoholics abstain for longer in trial

Next Post

New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities

Related Posts
Total
0
Share